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Abstract
Background: We aimed to investigate the clinical features associated with development of 
coronary collateral circulation (CCC) in patients with acute non-ST-elevation myocardial 
infarction (NSTEMI) and to develop a scoring model for predicting poor collateralization at 
hospital admission.
Methods: The study enrolled 224 consecutive patients with NSTEMI admitted to our coronary 
care unit. Patients were divided into poor (grade 0 and 1) and good (grade 2 and 3) CCC groups.
Results: In logistic regression analysis, presence of diabetes mellitus, total white blood cell 
(WBC) and neutrophil counts and neutrophil to lymphocyte ratio (NLR) were found as inde-
pendent positive predictors of poor CCC, whereas older age (≥ 70 years) emerged as a negative 
indicator. The final scoring model was based on 5 variables which were significant at p < 0.05 
level following multivariate analysis. Presence of diabetes mellitus, and elevated total WBC  
(≥ 7.85 × 103/µL) and neutrophil counts (≥ 6.25 × 103/µL) were assigned with 2 points; high 
NLR (≥ 4.5) with 1 point and older age (≥ 70 years old) with –1 point. Among 30 patients 
with risk score £ 1, 29 had good CCC (with a 97% negative predictive value). On the other 
hand, 139 patients had risk score ≥ 4; out of whom, 130 (with a 93.5% positive predictive 
value) had poor collateralization. Sensitivity and specificity of the model in predicting poor col-
lateralization in patients with scores £ 1 and ≥ 4 were 99.2% (130/131) and +76.3 (29/38), 
respectively.
Conclusions: This study represents the first prediction model for degree of coronary collater-
alization in patients with acute NSTEMI. (Cardiol J 2016; 23, 1: 107–113)
Key words: coronary collateral circulation, non-ST-elevation myocardial  
infarction, risk scoring
Introduction
The apparent prognostic implications of 
coronary collateral circulation (CCC) makes it 
necessary to have a better understanding of the 
factors promoting collateral development. In this 
study, we aimed to investigate the clinical features 
associated with development of CCC in patients 
with acute non-ST-elevation myocardial infarc-
tion (NSTEMI) and to develop a scoring model 
for predicting poor collateralization at hospital 
admission.
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Methods
We prospectively enrolled 224 consecutive 
patients with NSTEMI admitted to our coronary 
care unit within 24 h of symptom onset and sched-
uled to undergo coronary angiography within 
48 h of hospitalization. Patients who did not have 
a significant stenosis (≥ 70%) in at least one of 
the major epicardial coronary arteries in coronary 
angiograms were excluded from the study. Left 
main coronary artery narrowing of ≥ 50% was also 
considered significant. NSTEMI was diagnosed in 
the presence of two following criteria: (1) an ac-
celerating pattern of prolonged (lasting > 20 min) 
angina or recurrent episodes of angina either at 
rest or during minimal exertion within the 48 h; 
and (2) levels of cardiac biomarkers (troponin or 
creatine kinase MB isoenzymes) above the upper 
limit of the normal range. The exclusion criteria 
were overt congestive heart failure, idiopathic 
dilated or hypertrophic cardiomyopathy, chronic 
active pulmonary disease, history of renal or he-
patic dysfunction, inflammatory rheumatic disease, 
recent infection, cancer, and pregnancy.
According to our early invasive strategy, 
quantitative coronary angiography was performed 
in all patients within 48 h after admission in mul-
tiple orthogonal projections using the Judkins 
technique by 2 experienced independent inter-
ventional cardiologists. Decisions regarding the 
revascularization method were left to the discre-
tion of the interventionalists. When percutaneous 
coronary intervention was believed appropriate 
on the basis of coronary anatomy, culprit vessel 
stenting was performed in the same setting. In 
the case of multivessel interventions, non-culprit 
vessels could be revascularized in the same setting 
or in a staged procedure. Coronary collateral grad-
ing was carried out by 2 experienced cardiologists 
who are not informed of the clinical characteristics 
and biochemical results of the study patients. 
Collateral development was graded according to 
the Cohen-Rentrop method [1]: grade 0 (no filling 
of any collateral vessels); grade 1 (filling of side 
branches of the artery to be perfused by collat-
eral vessels without visualization of the epicardial 
segment); grade 2 (partial filling of the epicardial 
segment by collateral vessels); grade 3 (complete 
filling of the epicardial artery by collateral ves-
sels). Patients were then divided into two groups 
according to their collateral grades; with the first 
group having poorly developed CCC (grade 0 and 1) 
and the second group having well-developed CCC 
(grade 2 and 3).
Blood samples at hospital admission were 
drawn in the emergency room from the antecubital 
vein by careful venipuncture using a 21-gauge 
needle attached to a sterile syringe without sta-
sis. Hematological parameters such as red blood 
cells, platelets, white blood cells (WBC) and 
their subtypes were measured in blood collected 
in dipotassium ethylenediaminetetraacetic acid 
(EDTA) containing tubes by flow cytometry in an 
automated blood cell counter (Sysmex, XT-2000i) 
immediately within 30 min after sampling. Neu-
trophil to lymphocyte ratio (NLR) was calculated 
as the mean value of the ratio of neutrophils to 
lymphocytes, both obtained from the same blood 
sample.
The study was approved by the local bioethi-
cal committee and all patients gave their informed 
consent.
Statistical analysis
Statistical Package for Social Sciences (SPSS) 
version 17.0 (SPSS Inc., Chicago, Illinois, USA) 
was used for all statistical calculations. A 2-tailed 
p value lower than 0.05 was considered to be sta-
tistically significant. The categorical variables were 
shown as numbers of cases with percentages. Con-
tinuous variables were defined as mean ± standard 
deviation for parametric; and median with minimum 
and maximum levels for nonparametric variables. 
Student’s t-test was used for analysis of continuous 
variables that were normally distributed. The c2 test 
(or Fisher’s Exact test if required by sample size) 
was used to compare categorical data. The possible 
factors identified with univariate testing were fur-
ther entered into multiple logistic regression analy-
sis to determine the independent predictors of poor 
collateralization. A scoring system for prediction of 
poor collateralization was developed depending on 
the results of logistic regression analysis as just 
previously described [2]. Briefly, the lowest regres-
sion coefficient (B value) of significant parameters 
in multivariate analysis was scored with 1 point. 
Regression coefficients of other significant param-
eters were divided by the lowest one and the results 
were rounded to the nearest integer. Consequently, 
every significant parameter in logistic regression 
analysis was scored with a point correlated with its 
impact. These individual points were then added 
together to provide a total risk score for every 
patient. Receiver operating characteristic (ROC) 
curve analysis was performed as needed in order 
to determine the best cut-off values for numerical 
values including the developed score in prediction 
of poor collateralization.
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Results
Univariate analysis
Baseline clinical characteristics and labora-
tory findings including hematological parameters 
in study population at hospital admission were 
summarized in Table 1. Data also included the 
comparison of these parameters in poor and good 
CCC groups. A total of 224 patients (146 male 
and 78 female, mean age 65 ± 9 years old) were 
enrolled in this study. Rentrop coronary grade was 
distributed as followed among patients: 92 (41.1%) 
with grade 0, 53 (23.7%) with grade 1, 47 (21.0%) 
with grade 2 and 32 (14.3%) with grade 3. There 
were 145 patients in poor CCC group and 79 pa-
tients in good CCC group. Both groups were similar 
in terms of the presence of hyperlipidemia, body 
mass index, left ventricular ejection fraction, pre-
vious medications and biochemical measurements 
(serum creatinine, uric acid, gamma-glutamyl 
transferase, troponin). Poor CCC group included 
fewer patients ≥ 70 years old and more female 
gender compared to good CCC group (19.3% vs. 
43.0%, p < 0.001 and 40.7% vs. 24.01%, p = 0.028, 
respectively). Diabetes mellitus, hypertension and 
cigarette smoking were more common in poor col-
lateralization group compared with good collater-
alization (71 vs. 21, p < 0.001; 87 vs. 24, p < 0.001 
and 94 vs. 40, p = 0.038, respectively). Among the 
hematological parameters; red blood cell, platelet, 
lymphocyte and monocyte counts and platelet to 
lymphocyte ratio did not differ between the two 
groups. However, WBC count, neutrophil count 
and NLR were significantly higher in the poor CCC 
group compared to the good CCC group (9.01 ± 
± 0.95 vs. 7.57 ± 0.35, p < 0.001; 7.29 ± 0.81 vs. 
6.00 ± 0.33, p < 0.001 and 5.37 ± 1.03 vs. 4.31 ± 
± 0.63, p < 0.001, respectively). Angiographic 
and procedural characteristics in two groups were 
shown in Table 1. Patients with poor CCC had lower 
degree of stenosis (% of luminal diameter) in the 
culprit vessel (78.1 ± 8.3 vs. 83.6 ± 9.8, p < 0.001) 
compared to those with good CCC.
Multivariate analysis
The possible factors identified in univariate 
testing (age, gender, diabetes mellitus, hyperten-
sion, smoking, WBC count, neutrophil count and 
NLR) were further entered into logistic regression 
analysis to determine the independent predictors of 
poor CCC (Table 2). In multivariate analysis, pres-
ence of diabetes mellitus, WBC count, neutrophil 
count and NLR were found as independent po - 
sitive predictors of poor CCC whereas older age 
(≥ 70 years) emerged as a negative indicator. The 
final model was based on 5 variables which were 
significant at the p < 0.05 level following multivari-
able logistic regression analysis. The score includes 
these variables namely; age, diabetes mellitus, 
WBC count, neutrophil count and NLR. Optimal 
cut-off values for WBC count, neutrophil count, and 
NLR as determined by ROC analysis were 7.85 × 
× 103/µL, 6.25 × 103/ µL and 4.5, respectively. 
These three parameters were still significantly 
associated with CCC when they were categorized 
by their cut-off levels.
Model for prediction of poor CCC
As shown in Table 3, presence of diabetes 
mellitus, and high levels of WBC (≥ 7.85 × 103/µL) 
and neutrophil counts (≥ 6.25 × 103/µL) were 
assigned with 2 points; high NLR (≥ 4.5) with 
1 point and older age (≥ 70 years old) with –1 point. 
Consequently the score ranged between –1 to 
7 points. Table 4 summarizes the comparison of 
risk scores in patients with poor and good CCC. 
Among 30 patients with risk score £ 1, 29 had good 
CCC (with a 97% negative predictive value). On 
the other hand, 139 patients had risk score ≥ 4; 
out of whom, 130 (with a 93.5% positive predictive 
value) had poor collateralization. Consequently, the 
model was informative in 169 patients out of 224 
(75.4%) with their scores either £ 1 (n = 30) or 
≥ 4 (n = 139). Sensitivity and specificity of the 
model in predicting poor collateralization in patients 
with scores £ 1 and ≥ 4 were 99.2% (130/131) and 
+76.3 (29/38), respectively.
Discussion
Coronary collateral flow can provide an alter-
native blood supply to myocardium jeopardized by 
stenosis or occlusion of a coronary artery. A recent 
meta-analysis of 12 studies enrolling 6,529 patients 
evaluated the effect of collateral function on all 
cause mortality in a mixed population of coronary 
artery disease (CAD) [3]. Results showed that pa-
tients with well developed collaterals had reduced 
mortality compared to those with poor collaterals. 
These data suggest that assessment of collateral 
function might be useful for risk stratification in pa-
tients with CAD. Our study group includes patients 
with acute NSTEMI. In the presence of persistent 
coronary occlusion, coronary collateral flow in the 
infracted area tends to increase in the days and 
weeks following the acute event. However, some 
investigators have shown that even in the first 
6 h following acute coronary occlusion, collateral 
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Table 1. Baseline clinical and laboratory findings in study population; comparison between poor and 
good coronary collateral circulation (CCC) groups.
All (n = 224) Poor CCC (n = 145) Good CCC (n = 79) P
Clinical and laboratory findings
Age ≥ 70 years 62 (27.7%) 28 (19.3%) 34 (43.0%) < 0.001
Female 78 (34.8%) 59 (40.7%) 19 (24.01%) 0.028
Body mass index [kg/m2] 32.68 ± 5.58 32.73 ± 5.40 32.65 ± 6.57 0.912
Diabetes mellitus 92 (41.1%) 71 (48.9%) 21 (26.5%) < 0.001
Hypertension 111 (49.6%) 87 (60.0%) 24 (30.3%) < 0.001
Hypercholesterolemia 94 (42.0%) 63 (43.4%) 31 (39.2%) 0.542
Current smoking 134 (59.8%) 94 (64.8%) 40 (50.6%) 0.038
History of angina pectoris 98 (43.8%) 56 (38.6%) 42 (53.2%) 0.13
Left ventricular ejection fraction [%] 51.0 ± 10.8 50.8 ± 11.5 51.4 ± 9.6 0.662
Peak troponin I [ng/mL] 6.8 ± 8.0 6.8 ± 8.7 6.7 ± 6.5 0.909
Serum creatinine [mg/dL] 1.19 ± 0.5 1.17 ± 0.46 1.2 ± 0.5 0.64
Uric acid [mg/dL] 5.4 ± 5.1 5.7 ± 6.3 5.1 ± 1.7 0.421 
Gamma-glutamyl transferase [U/L] 23.9 ± 19.3 24.9 ± 21.3 2.22 ± 15.2 0.319
Previous medications
Aspirin 75 (33.5%) 45 (32.0%) 30 (37.9%) 0.453
Statin 44 (19.6%) 27 (18.6%) 17 (21.5%) 0.602
Nitrates 32 (14.3%) 5 (10.3%) 17 (21.5%) 0.82
ACEI/ARB 62 (27.7%) 42 (28.9%) 20 (25.3%) 0.560
Beta-blockers 91 (40.6%) 60 (41.3%) 31 (39.2%) 0.755
CCB 61 (27.2%) 41 (28.2%) 20 (25.3%) 0.634
Hematological parameters
Red blood cell count [×106/µL] 5.20 ± 0.52 5.24 ± 0.51 5.13 ± 0.55 0.139
Platelet count [×103/µL] 225.42 ± 87.52 250.11 ± 85.44 265.19 ± 90.98 0.219
WBC count [×103/µL] 8.50 ± 1.05 9.01 ± 0.95 7.57 ± 0.35 < 0.001
WBC subtype:
      Neutrophil [×103/µL] 6.83 ± 0.92 7.29 ± 0.81 6.00 ± 0.33 < 0.001
      Lymphocyte [×103/µL] 1.40 ± 0.24 1.40 ± 0.25 1.42 ± 0.22 0.44
      Monocyte [×103/µL] 0.46 ± 0.20 0.46 ± 0.21 0.45 ± 0.17 0.808
      NLR 4.99 ± 1.04 5.37 ± 1.03 4.31 ± 0.63 < 0.001
      P/L ratio 186.09 ± 69.20 184.18 ± 70.42 189.61 ± 67.21 0.576
Angiographic and procedural characteristics
Number of diseased vessels 1.7 ± 0.8 1.7 ± 0.2 1.8 ± 0.4 0.46
Culprit vessel:
LM 8 (3.6%) 7 (4.8%) 1 (0.0%) 0.559
LAD 111 (49.6%) 71 (48.9%) 40 (50.6%)
LCX 71 (31.7%) 44 (30.3%) 27(34.1%)
RCA 25 (11.2%) 18 (12.4%) 7 (8.8%)
Culprit not clearly identified 9 (4%) 5 (3.4%) 4 (5.1%)
Stenosis of culprit vessel [%] 80.1 ± 9.2 78.1 ± 8.3 83.6 ± 9.8 < 0.001
Treatment decision:
PCI 198 (88.4%) 130 (89.6%) 75 (94.9%) 0.519
CABG 7 (3.1%) 6 (4.1%) 1 (1.2%)
Conservative 12 (5.4%) 9 (6.2%) 3 (3.7%)
Rentrop grade:
0 92 (41.1%)
1 53 (23.7%)
2 47 (21.0%)
3 32 (14.3%)
ACEI — angiotensin converting enzyme inhibitors; ARB — angiotensin receptor blocker; CCB — calcium-channel blockers; WBC — white 
blood cell; NLR — neutrophil to lymphocyte ratio, P/L — platelet to lymphocyte; LM — left main; LAD — left anterior descending; LCX — left 
circumflex; RCA — right coronary artery; PCI — percutaneous coronary intervention; CABG — coronary artery bypass graft
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flow may increase significantly over time [4]. In 
a previous study population, angiographic collaterals 
to myocardial tissue distal to an acutely occluded 
coronary vessel were detected in 69% patients dur-
ing the acute phase [5]. This prevalence increased 
to 75% between 3 h and 6 h following symptom 
onset. Some other reports also showed early evi-
dence of angiographic collateral vessels in acute 
ST-elevation myocardial infarction and NSTEMI [6]. 
The protective effects of angiographically visible 
collateral vessels in acute setting of infarction 
include a reduction in ischemic damage and preven-
tion of fatal arrhythmias and aneurysm formation 
[7]. Residual blood flow carried by collaterals at 
the time of acute occlusion is also associated with 
positively influenced post infarct re-modeling and 
preserved myocardial function [8]. Therefore, we 
have a considerable interest in developing a model 
to assess the degree of coronary collateralization 
in the setting of an acute NSTEMI. Prior to our 
study, no scoring model for predicting poor collat-
eral vessels in patients with acute infarction has 
been established.
Our study showed that presence of diabetes 
mellitus, elevated WBC and neutrophil counts and 
NLR on admission were independent predictors of 
poor CCC in patients with acute NSTEMI, whereas 
older age emerged as a negative indicator. Based 
on the results of the logistic regression analysis, 
we developed a simplified clinical score to predict 
poor collateral development by transforming the 
regression coefficient of each variable into an 
equivalent accurately weighted risk integer score. 
Therefore, poor collateralization can be easily 
and accurately assessed from simple clinical and 
laboratory variables on initial presentation of the 
patient in emergency room. The risk factors are 
all routinely measured and do not require expen-
sive, time consuming or complicated technology 
to investigate. The clinician would simply collect 
routine data, total the scores for each variable, 
then predict the degree of collateralization. The 
final model was based on 5 variables which were 
significant at the p < 0.05 level following multivari-
able logistic regression analysis. The total score for 
each patient was calculated by assigning 2 points 
Table 2. Multivariate logistic regression analysis to find the independent predictors of poor collateral 
development in study patients.
B SE Sig. Exp (B) 95% confidence interval Exp (B)
Lower Upper
Neutrophil (≥ 6.25 ×103/µL) 3.099 0.732 0.000 22.169 5.279 93.110
NLR (≥ 4.5) 1.400 0.599 0.019 4.056 1.254 13.113
WBC (≥ 7.85 ×103/µL) 2.487 0.691 0.000 12.030 3.106 46.591
Age (≥ 70 years) –1.652 0.621 0.008 0.192 0.057 0.647
Diabetes mellitus 2.757 0.766 0.000 15.748 3.512 70.613
Male 0.566 0.568 0.319 1.761 0.579 5.361
Hypertension 0.658 0.546 0.228 1.931 0.662 5.629
Smoking 1.008 0.566 0.075 2.741 0.903 8.319
B — regression coefficient; NLR — neutrophil to lymphocyte ratio; WBC — white blood cell
Table 3. Simplified MILERI score calculation as 
transformed from the regression coefficients.
Score element B Score point
Neutrophil (≥ 6.25 ×103/µL) 3.099 2
NLR (≥ 4.5) 1.400 1
WBC (≥ 7.85 × 103/µL) 2.487 2
Age (≥ 70 years) –1.652 –1
Diabetes mellitus 2.757 2
B — regression coefficient for the parameter; NLR — neutrophil to 
lymphocyte ratio; WBC — white blood cell
Table 4. Comparison of MILERI scores in study 
patients with poor and good coronary collateral 
circulation (CCC).
MILERI  
score
Poor  
CCC 
Good 
CCC
Total P
£ 1 1 29 30 < 0.001
2–3 14 41 55
≥ 4 130 9 139
Total 145 79 224
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for elevated WBC (≥ 7.85 × 103/µL) and neutrophil 
(≥ 6.25 × 103/µL) counts, 1 point for NLR (≥ 4.5) 
and –1 point for older age (≥ 70 years old). The cut 
of values for each parameter were identified in the 
ROC curve analysis. The model was informative 
in 75% of patients with scores either £ 1 or ≥ 4. 
Sensitivity and specificity of the model in predicting 
poor collateralization in these patients were 99.2% 
and 76.3%, respectively. The model has excellent 
predictive ability in selected patients.
Collateral development is a complex multi-
step process. It involves multiple inflammatory 
cell types as well as components of the extracel-
lular matrix. Previous studies have shown that 
poor collateralization in CAD was related to a low 
grade inflammation, as evidenced by increased 
high sensitive C reactive protein levels [9, 10]. 
Acute-phase reactants and inflammatory cytokines 
such as tumor necrosis factor-a and interleukin-6 
have been found to be the predictors of insufficient 
coronary collaterals [11]. Some investigators also 
reported an association between poorly developed 
collateral vessels and an elevated concentration of 
soluble adhesion molecules [12]. These data have 
clearly demonstrated that increased inflammatory 
activity was associated with poor collateraliza-
tion. WBC and its subtypes play a major role in 
modulating the inflammatory response. Effect of 
total leukocyte count on adverse coronary events 
is well demonstrated in the literature, however 
the data on the relationship between leukocyte 
subtypes and coronary collateral development is 
insufficient. At the cellular level, inflammatory 
cells play an important role in collateralization. 
In a series of experimental studies with animals, 
monocytes were shown to be essential elements 
for collateral development [13]. Higher circulating 
monocyte counts related to good collateral develop-
ment in patients with stable angina [14]. A recent 
study relieved that increased CD14++CD16– 
monocyte count predicts good collateralization in 
patients with stable angina [15]. On the other hand, 
two previous papers found increased leukocyte 
counts to be associated with poorly developed 
CCC in chronic total occlusion [16, 17]. In contrast 
to these findings, some investigators think that 
proinflammatory enzymes and cytokines released 
from these cells rather than leukocytes may play 
a role on collateral development in chronic total 
occlusion [18]. Currently, there are insufficient 
data regarding the relation between white blood 
cell subtypes and collateral development in acute 
infarction. Because ischemia during acute coronary 
occlusion appears to be a trigger for recruitment 
of leukocytes, we sought to investigate whether 
leukocyte subtypes in peripheral blood are related 
to the degree of collateral function in patients with 
acute infarction. We studied patients with acute 
NSTEMI and found that red blood cell and platelet 
counts did not differ between two groups with poor 
and good CCC. Lymphocyte and monocyte counts 
and platelet to lymphocyte ratios were also similar. 
However, patients with poor CCC have significantly 
higher WBC and neutrophil counts compared to 
those with good CCC.
Leukocytosis is a common finding in acute 
myocardial infarction that reflects the infiltration of 
WBCs into damaged tissue in response to ischemia 
and reperfusion. Particularly NLR is a combined 
factor of both inflammation and immune reaction. 
As a simple and noninvasive marker, NLR, in part 
of blood count, is a recent emerged better reflector 
of inflammation and endothelial dysfunction which 
have been evaluated widely in several cardiovascu-
lar diseases. Recently, a few studies revealed that 
elevated NLR was associated with impaired collat-
eralization, however patients in these reports had 
stable CAD with chronic coronary total occlusions 
[17, 19–22]. No data are available investigating 
the association of NLR with collateral function in 
acute setting of myocardial infarction. In our study, 
patients with poor CCC had significantly higher 
NLR compared to those with good collateralization. 
We found that NLR is an independent predictor of 
poor collateral development in acute NSTEMI. The 
association between NLR and poor collateralization 
may be explained by increased inflammatory activ-
ity and endothelial dysfunction, since a higher NLR 
indicates a higher level of inflammation. Whether 
it is the cause or the effect, NLR is associated 
with poor collateralization in the setting of acute 
myocardial infarction.
Our finding was consistent with previous 
data indicating that collateral growth is impaired 
in type-2 diabetes and metabolic syndrome [23, 
24]. One of the major characteristics of diabetes 
is the persistent baseline inflammatory state 
characterized by elevated oxidative stress and 
endothelial dysfunction consistently observed in 
the vasculature and the myocardium. Endothelial 
cell function is essential for collateral formation. 
Nitric oxide is critically required for collateral 
development. Accordingly, diabetes mellitus and 
metabolic syndrome severely impair coronary col-
lateral growth. In contrast to other studies, our data 
confirmed a negative association between older 
age and poor collateralization. Age emerged as 
a negative predictor of impaired collateralization in 
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our scoring model. There has been some evidence 
from experimental studies that aging negatively af-
fects collateral remodeling via impaired endothelial 
nitric oxide synthase pathways and by increased 
oxidative stress in coronary arterioles [25]. How-
ever, in the setting of an acute infarction, the hu-
man collateral function can be a direct indicator of 
CAD severity. Elderly patients probably have more 
severe disease which itself positively influences 
collateral development.
Conclusions
This study presents the first prediction model 
for degree of coronary collateralization in patients 
with acute NSTEMI. Our score uses simple clinical 
and laboratory parameters that are readily available 
for bedside use and provides a valuable tool for 
clinical decision-making.
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